Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial.

By L. Sjöström, Anders Gummesson, C. Sjöström, K. Narbro, Markku Peltonen, H. Wedel, C. Bengtsson, C. Bouchard, B. Carlsson, S. Dahlgren and 11 more. The Lancet Oncology, 2009

746 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/2757fd98d04cc43a313c026bf805d03ef41644a7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. G. De Pergola
2. J. Slingerland
3. F. Silvestris

In Oncology

1. G. De Pergola
2. F. B. Hu
3. J. Slingerland
4. F. Silvestris

In Surgery

1. G. De Pergola
2. F. B. Hu
3. L. Angrisani
4. C. Mantzoros
5. J. Himpens
6. Judith Hochman
7. F. Silvestris
8. T. Wadden

Citations in the corpus

• Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers (2019, background): “(54) and demonstrated long-term safety as pharmacologic therapy for diabetes prevention (52).”
• 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. (2022, background): “[135] Sjostrom L, Gummesson A, Sjostrom CD, et al.”
• AMPK, insulin resistance, and the metabolic syndrome. (2013, neutral): “The latter comprise approximately 75% of bariatric surgery patients and show a greater predisposition to metabolic syndrome–associated diseases than do the remaining 25% of such patients who are equally obese, but less hyperinsulinemic and more insulin sensitive (17–19).”
• Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention (2017, result): “Two prospective cohort studies that included 4047 and 16,038 obese patients, respectively, reported that bariatric surgery resulted in a weight reduction and was associated with reduced all-cancer incidence in obese women but had no significant effects in men.(62,63) Similarly, a prospective cohort ”
• Obesity and cancer risk: Emerging biological mechanisms and perspectives. (2019, background): “More importantly, bariatric surgery has been shown to reduce the incidence of many cancers such as endometrial, breast, colorectal, non-Hodgkin lymphoma and melanoma [55,231,232].”
• Obesity as a Major Risk Factor for Cancer (2013, background): “reduction in obese patients with BMI higher than 40 kg/m(2) and that matched the surgery group with untreated morbidly obese women, reported a significant reduction in cancer incidence in association with substantial weight loss on a followup longer than 10 years [14].”
• 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013, background): “The remaining 22 studies (35 articles) which met the criteria for at least 1 of the 3 components were rated good or fair quality and included in the evidence base (139-173).”